Maria C Rodriguez-Oroz. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antiparkinson Agents/therapeutic useCognitionDeep Brain Stimulation/adverse effectsDeep Brain Stimulation/methodsDisease ProgressionDyskinesias/drug therapyDyskinesias/surgeryDyskinesias/therapyHumansMulticenter Studies as TopicParkinson Disease/drug therapyParkinson Disease/surgeryParkinson Disease/therapyQuality of LifeRandomized Controlled Trials as TopicSeverity of Illness IndexSubthalamic Nucleus/surgeryTime FactorsTreatment Outcome
Substances: See more » Antiparkinson Agents
Year: 2010 PMID: 20434404 DOI: 10.1016/S1474-4422(10)70108-3
Source DB: PubMed Journal: Lancet Neurol ISSN: 1474-4422 Impact factor: 44.182